Vertex Pharmaceuticals (Europe) Ltd's Net Worth

$350 Million

Estimate Recalculated Feb 21, 2024 05:50PM EST

Who is Vertex Pharmaceuticals (Europe) Ltd?

Vertex Pharmaceuticals (Europe) Ltd has an estimated net worth of $350 Million. This is based on reported shares in CRISPR Therapeutics AG.

SEC CIK

Vertex Pharmaceuticals (Europe) Ltd's CIK is 0001761216

Past Insider Trading and Trends

2018 was Vertex Pharmaceuticals (Europe) Ltd's most active year for acquiring shares with 6 total transactions. Vertex Pharmaceuticals (Europe) Ltd's most active month to acquire stocks was the month of November. 2018 saw Vertex Pharmaceuticals (Europe) Ltd paying a total of $3,187,153.85 for 130,940 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CRISPR Therapeutics AG (CRSP) Snapshot price: $65.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.75%
40.2K
$24.93
$1,002,193.68
5.38M
Dec 26 - Dec 27
Form 4
+1.73%
90.74K
$24.08
$2,184,960.17
5.34M
Dec 21 - Dec 24
Form 3
0
0
No matching records found